News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shaw Christi
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/15/2023 |
4
| Shaw Christi (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/16/2022 |
4
| Shaw Christi (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 6,693 shares
@ $0 |
|
| 04/05/2022 |
4
| Shaw Christi (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 1,215 shares
@ $0 |
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Shaw Christi (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 14,286 shares
@ $26.68, valued at
$381.2k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2019 |
4
| Shaw Christi (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 14,286 shares
@ $0 |
|
| 05/07/2019 |
4
| Shaw Christi (SVP and Pres., Lilly Bio-Meds) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Sold 7,077 shares
@ $117.08, valued at
$828.6k
Sold 500 shares
@ $117.99, valued at
$59k
|
|
| 05/03/2019 |
4
| Shaw Christi (SVP and Pres., Lilly Bio-Meds) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Paid exercise price by delivering 6,173 shares
@ $117.04, valued at
$722.5k
Exercised 13,750 restricted stock units
@ $0 |
|
| 05/31/2018 |
4
| Shaw Christi (SVP and Pres., Lilly Bio-Meds) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Sold 8,426 shares
@ $82.1, valued at
$691.8k
|
|
| 05/03/2018 |
4
| Shaw Christi (SVP and Pres., Lilly Bio-Meds) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Paid exercise price by delivering 5,324 shares
@ $81.07, valued at
$431.6k
Exercised 13,750 restricted stock units
@ $0 |
|
| 05/08/2017 |
4
| Shaw Christi (SVP and Pres., Lilly Bio-Meds) has filed a Form 4 on LILLY ELI & CO|
Txns:
| Granted 27,500 restricted stock units
@ $0 |
|
|
|